假体周围关节感染患者的院内死亡率
基于美国全国住院患者样本2002至2010年数据,假体周围关节感染(PJI)患者的院内死亡率为0.77%,高于无菌性翻修者的0.38%,比值比为2.05(P<.0001)。PJI翻修全髋关节置换的院内死亡率高于冠状动脉介入、胆囊切除术、肾移植和颈动脉手术。作者认为PJI可能致命,控制感染有助于降低死亡风险。
要点
- PJI患者院内死亡率为0.77%,无菌性翻修者为0.38%,比值比为2.05(P<.0001)。
- PJI翻修全髋关节置换的院内死亡率高于冠状动脉介入、胆囊切除术、肾移植和颈动脉手术。
- 作者认为PJI可能致命,外科医生应认识感染控制对降低死亡风险的重要性。
核心结论
- PJI患者每次手术入院的院内死亡风险约为无菌性翻修者的2倍,比值比为2.05(P<.0001)。
- 由于PJI患者常多次入院,且该分析按手术入院计算,每增加一次手术,死亡风险会累积。
- 作者认为外科医生应认识PJI可能致命,以及控制感染对降低死亡风险的重要性。
研究设计与样本
- 基于美国全国住院患者样本(Nationwide Inpatient Sample)2002至2010年数据的分析。
- 比较PJI患者与无菌性失败翻修关节置换患者的院内死亡风险。
- 采用Elixhauser合并症指数获取患者合并症,并用多元逻辑回归分析PJI及其他患者相关因素与死亡率的关联。
主要发现
- PJI患者院内死亡率为0.77%,无菌性翻修者为0.38%,PJI与院内死亡风险升高相关,比值比为2.05(P<.0001)。
- PJI翻修全髋关节置换的院内死亡率高于冠状动脉介入(1.22%;95%CI,1.20-1.24)。
- PJI翻修全髋关节置换的院内死亡率高于胆囊切除术(1.13%;95%CI,1.11-1.15)。
- PJI翻修全髋关节置换的院内死亡率高于肾移植(0.70%;95%CI,0.61-0.79)。
- PJI翻修全髋关节置换的院内死亡率高于颈动脉手术(0.89%;95%CI,0.86-0.93)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While periprosthetic joint infection (PJI) has a huge impact on patient function and health, only a few studies have investigated its impact on mortality. The purpose of this large-scale study was to (1) determine the rate and trends of in-hospital mortality for PJI and (2) compare the in-hospital mortality rate of patients with PJI and those undergoing revision arthroplasty for aseptic failure and patients undergoing other nonorthopedic major surgical procedures. METHODS: Data from the Nationwide Inpatient Sample from 2002 to 2010 were analyzed to determine the risk of in-hospital mortality for PJI patients compared with aseptic revision arthroplasty. The Elixhauser comorbidity index was used to obtain patient comorbidities. Multiple logistic regression analyses were used to examine whether PJI and other patient-related factors were associated with mortality. RESULTS: PJI was associated with an increased risk (odds ratio, 2.05; P < .0001) of in-hospital mortality (0.77%) compared with aseptic revisions (0.38%). The in-hospital mortality rate of revision total hip arthroplasties with PJI was higher than those for interventional coronary procedures (1.22%; 95% confidence interval [CI], 1.20-1.24), cholecystectomy (1.13%; 95% CI, 1.11-1.15), kidney transplant (0.70%; 95% CI, 0.61-0.79), and carotid surgery (0.89%; 95% CI, 0.86-0.93). CONCLUSION: Patients undergoing treatment for PJI have a 2-fold increase in in-hospital mortality for each surgical admission compared to aseptic revisions. Considering that PJI cases often have multiple admissions and that this analysis is by surgical admission, the risk of mortality will accumulate for every additional surgery. Surgeons should be cognizant of the potentially fatal outcome of PJI and the importance of infection control to reduce the risk of mortality.
引用
- Shahi A, Tan TL, Chen AF, et al. In-Hospital Mortality in Patients With Periprosthetic Joint Infection. J Arthroplasty. 2016. PMID: 27816369. doi:10.1016/j.arth.2016.09.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。